malondialdehyde and Scleroderma, Systemic
malondialdehyde has been researched along with Scleroderma, Systemic in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ansari, GAS; Khan, MF; Wang, G; Wang, J | 1 |
Clifton, HL; Donato, AJ; Frech, TM; Groot, HJ; Machin, DR; Richardson, RS; Wray, DW | 1 |
Jiang, M; Liu, X; Luo, JY; Zhao, HP; Zhao, JJ | 1 |
Devrim, E; Durak, I; Erguder, IB; Erten, S; Namuslu, M; Turgay, M | 1 |
Bagchi, D; Cerinic, MM; Das, DK; Del Rosso, A; Generini, S; Kalin, R; Righi, A | 1 |
Allanore, Y; Borderie, D; Ekindjian, OG; Kahan, A; Lemaréchal, H | 1 |
Channa, K; Gulumian, M; Theodorou, P; Tikly, M | 1 |
Balbir-Gurman, A; Boikaner, T; Braun-Moscovici, Y; Livshitz, V; Markovits, D; Nahir, AM; Rozin, A; Schapira, D | 1 |
Auclair, C; Deroussent, A; Emerit, I; Fernandes, A; Filipe, P; Freitas, J; Gouyette, A; Meunier, P | 1 |
Bancroft, A; Belch, JJ; Bridges, AB; Lau, CS; Muir, A; Scott, N | 1 |
Kudriavtseva, GV; Makarov, SA; Shishkin, VI | 1 |
Reviews
1 review(s) available for malondialdehyde and Scleroderma, Systemic
Article | Year |
---|---|
Oxidative stress markers in blood in systemic sclerosis: A meta-analysis.
Topics: Arginine; Ascorbic Acid; Biomarkers; Case-Control Studies; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Scleroderma, Systemic; Superoxide Dismutase | 2017 |
Trials
2 trial(s) available for malondialdehyde and Scleroderma, Systemic
Article | Year |
---|---|
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.
Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Scleroderma, Systemic; Sulfhydryl Compounds; Time Factors | 2004 |
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.
Topics: Adult; Antioxidants; Catalase; Ceruloplasmin; Female; Humans; Iloprost; Malondialdehyde; Middle Aged; Oxidative Stress; Platelet Aggregation Inhibitors; Raynaud Disease; Scleroderma, Systemic; Superoxide Dismutase | 2007 |
Other Studies
8 other study(ies) available for malondialdehyde and Scleroderma, Systemic
Article | Year |
---|---|
Autoimmune potential of perchloroethylene: Role of lipid-derived aldehydes.
Topics: Animals; Antibodies; Autoimmunity; Cell Proliferation; Disease Models, Animal; Female; Glutathione; Interleukin-17; Lipids; Lupus Erythematosus, Systemic; Malondialdehyde; Mice; Protein Binding; Scleroderma, Systemic; Solvents; Spleen; Superoxide Dismutase; Tetrachloroethylene; Th17 Cells | 2017 |
Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement.
Topics: Biological Availability; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Humans; Inflammation; Leg; Male; Malondialdehyde; Middle Aged; Movement; Nitric Oxide; Oxidative Stress; Regional Blood Flow; Scleroderma, Systemic | 2018 |
Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis.
Topics: Antioxidants; Case-Control Studies; Erythrocytes; Fasting; Female; Humans; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Scleroderma, Systemic | 2008 |
Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis.
Topics: Activins; Anthocyanins; Cell Adhesion; E-Selectin; Humans; Inflammation; Intercellular Adhesion Molecule-1; Malondialdehyde; Models, Chemical; Oxidative Stress; Pilot Projects; Plant Extracts; Proanthocyanidins; Scleroderma, Systemic; Seeds; Vascular Cell Adhesion Molecule-1; Vitis | 2002 |
Lipid peroxidation and trace elements in systemic sclerosis.
Topics: Case-Control Studies; Disability Evaluation; Female; Health Status; Humans; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Scleroderma, Systemic; Skin; Surveys and Questionnaires; Time Factors; Trace Elements | 2006 |
Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress.
Topics: Adenosine Deaminase; Adult; Aged; Antioxidants; Biomarkers; Colorimetry; Electrochemistry; Esophageal Diseases; Female; Humans; Inosine Triphosphate; Lipid Peroxidation; Male; Malondialdehyde; Mass Spectrometry; Middle Aged; Mutagens; Oxidative Stress; Scleroderma, Systemic; Skin Diseases; Superoxide Dismutase; Superoxides | 1997 |
Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon.
Topics: Adult; Aged; Cell Adhesion; Female; Humans; Male; Malondialdehyde; Middle Aged; Neutrophils; Raynaud Disease; Scleroderma, Systemic; Severity of Illness Index | 1992 |
[Prostaglandins in the pathogenesis of various systemic diseases of the connective tissue].
Topics: Adult; Arthritis, Rheumatoid; Connective Tissue Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Prostaglandins; Scleroderma, Systemic | 1987 |